Cardiff Oncology CRDF
$ 2.51
-0.99%
Quarterly report 2024-Q3
added 11-07-2024
Cardiff Oncology Balance Sheet 2011-2024 | CRDF
Annual Balance Sheet Cardiff Oncology
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-19.5 M | -13.6 M | -8.82 M | -130 M | -8.47 M | -11.5 M | -6.89 M | 2.62 M | -51 M | -12.3 M | -25.3 M | -10.8 M | -700 K |
Long Term Debt |
1.46 M | 2.04 M | 2.57 M | - | - | - | - | 14.2 M | 11.2 M | 13.1 M | 323 K | - | - |
Long Term Debt Current |
691 K | 675 K | 551 K | 860 K | 865 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 451 K | 993 K | 1.12 M | 1.83 M | 16.4 M | 14.5 M | 16.1 M | 4.75 M | 8.77 M | 3.84 M |
Total Current Liabilities |
10.4 M | 7.81 M | 6.56 M | 6.12 M | 4.78 M | 2.97 M | 3.95 M | 7.8 M | 8.2 M | 4.49 M | 2.01 M | 730 K | - |
Total Liabilities |
11.9 M | 9.85 M | 9.13 M | 6.57 M | 5.78 M | 4.09 M | 5.78 M | 24.2 M | 22.7 M | 20.5 M | 6.76 M | 9.5 M | 5.27 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-340 M | -298 M | -260 M | -231 M | -209 M | -192 M | -173 M | -148 M | -109 M | -81.4 M | -67 M | -55.2 M | -43.6 M |
Total Assets |
81.6 M | 116 M | 150 M | 135 M | 13.1 M | 14.2 M | 12.3 M | 44 M | 71.4 M | 28.9 M | 27.2 M | 11.7 M | 1.04 M |
Cash and Cash Equivalents |
21.7 M | 16.3 M | 11.9 M | 131 M | 10.2 M | 11.5 M | 8.23 M | 13.9 M | 67.5 M | 27.3 M | 25.8 M | 10.8 M | 700 K |
Book Value |
69.7 M | 106 M | 140 M | 128 M | 7.31 M | 10.1 M | 6.51 M | 19.8 M | 48.7 M | 8.35 M | 20.4 M | 2.17 M | -4.23 M |
Total Shareholders Equity |
69.7 M | 106 M | 140 M | 128 M | 7.31 M | 10.1 M | 6.51 M | 19.8 M | 48.7 M | 8.35 M | 20.4 M | 2.17 M | -4.23 M |
All numbers in USD currency
Quarterly Balance Sheet Cardiff Oncology
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
979 K | 1.14 M | 1.3 M | 1.46 M | 1.61 M | 1.75 M | 1.9 M | 2.04 M | 2.17 M | - | 2.44 M | 2.57 M | 2.69 M | 6 K | 8 K | 9 K | 9 K | 9 K | 9 K | 861 K | 861 K | 861 K | 861 K | - | - | - | - | - | - | - | 12.7 M | 14.2 M | 14.2 M | 14.2 M | 14.2 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 323 K | 323 K | 323 K | 323 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
13.5 M | 13.7 M | 13.1 M | 11.9 M | 10.6 M | 10.9 M | 10 M | 9.85 M | 10.4 M | - | 9.1 M | 9.13 M | 7.77 M | 4.82 M | 4.76 M | 6.57 M | 6.57 M | 6.57 M | 6.57 M | 5.78 M | 5.78 M | 5.78 M | 5.78 M | 4.09 M | 4.09 M | 4.09 M | 4.09 M | 5.78 M | 5.78 M | 5.78 M | 5.78 M | 24.2 M | 24.2 M | 24.2 M | 24.2 M | 22.7 M | 22.7 M | 22.7 M | 22.7 M | 20.5 M | 20.5 M | 20.5 M | 20.5 M | 6.76 M | 6.76 M | 6.76 M | 6.76 M | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 5.27 M | 5.27 M | 5.27 M | 5.27 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-372 M | -361 M | -349 M | -340 M | -330 M | -320 M | -309 M | -298 M | -290 M | - | -271 M | -260 M | -250 M | -243 M | -237 M | -231 M | -231 M | -231 M | -231 M | -209 M | -209 M | -209 M | -209 M | -192 M | -192 M | -192 M | -192 M | -173 M | -173 M | -173 M | -173 M | -148 M | -148 M | -148 M | -148 M | -109 M | -109 M | -109 M | -109 M | -81.4 M | -81.4 M | -81.4 M | -81.4 M | -67 M | -67 M | -67 M | -67 M | -55.2 M | -55.2 M | -55.2 M | -55.2 M | -43.6 M | -43.6 M | -43.6 M | -43.6 M |
Total Assets |
62.9 M | 66.1 M | 74 M | 81.6 M | 88.5 M | 97.5 M | 107 M | 116 M | 124 M | - | 139 M | 150 M | 141 M | 144 M | 130 M | 135 M | 135 M | 135 M | 135 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 14.2 M | 14.2 M | 14.2 M | 14.2 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 44 M | 44 M | 44 M | 44 M | 71.4 M | 71.4 M | 71.4 M | 71.4 M | 28.9 M | 28.9 M | 28.9 M | 28.9 M | 27.2 M | 27.2 M | 27.2 M | 27.2 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 1.04 M | 1.04 M | 1.04 M | 1.04 M |
Cash and Cash Equivalents |
13 M | 25.5 M | 18.7 M | 21.7 M | 15.2 M | 19.4 M | 15 M | 16.3 M | 18.7 M | 21 M | 20.1 M | 11.9 M | 13.2 M | 10.6 M | 14.7 M | 131 M | 131 M | 131 M | 131 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 8.23 M | 8.23 M | 8.23 M | 8.23 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 67.5 M | 67.5 M | 67.5 M | 67.5 M | 67.5 M | 27.3 M | 27.3 M | 27.3 M | 25.8 M | 25.8 M | 25.8 M | 25.8 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | 700 K | 700 K | 700 K | 700 K |
Book Value |
49.4 M | 52.4 M | 60.9 M | 69.7 M | 77.8 M | 86.6 M | 96.5 M | 106 M | 113 M | - | 130 M | 140 M | 134 M | 139 M | 125 M | 128 M | 128 M | 128 M | 128 M | 7.31 M | 7.31 M | 7.31 M | 7.31 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 6.51 M | 6.51 M | 6.51 M | 6.51 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 48.7 M | 48.7 M | 48.7 M | 48.7 M | 8.35 M | 8.35 M | 8.35 M | 8.35 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 2.17 M | 2.17 M | 2.17 M | 2.17 M | -4.23 M | -4.23 M | -4.23 M | -4.23 M |
Total Shareholders Equity |
49.4 M | 52.4 M | 60.9 M | 69.7 M | 77.8 M | 86.6 M | 96.5 M | 106 M | 113 M | 120 M | 130 M | 140 M | 134 M | 139 M | 125 M | 128 M | 128 M | 128 M | 128 M | 7.31 M | 7.31 M | 7.31 M | 7.31 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 6.51 M | 6.51 M | 6.51 M | 6.51 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 48.7 M | 48.7 M | 48.7 M | 48.7 M | 8.35 M | 8.35 M | 8.35 M | 8.35 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 2.17 M | 2.17 M | 2.17 M | 2.17 M | -4.23 M | -4.23 M | -4.23 M | -4.23 M |
All numbers in USD currency